Open Beta
TREN
MetriLume
TREN

US marketsADAG

SEC-sourced researchBeta

ADAG

Adagene Inc.

Company comparison ↗

Data passport

CIK
0001818838
Exchange
Nasdaq
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 18,111,491.0000 USD; December 2024: 103,204.0000 USD; December 2025: 7,670,902.0000 USD18.1M USD0 USD0December 2023December 2024December 2025
ADAG · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202318,111,491.0000Apr 1, 2026
December 2024103,204.0000Apr 1, 2026
December 20257,670,902.0000Apr 1, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20257,670,902.0000-17,609,413.0000-15,657,450.000078,263,297.000026,363,750.0000Apr 1, 2026
December 2024103,204.0000-33,424,111.0000-29,700,985.000089,268,425.000038,744,581.0000Apr 1, 2026
December 202318,111,491.0000-18,946,370.0000-28,454,839.0000——Apr 1, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

53/100
Profitability0
Growth100
Balance sheet66
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$7.67MJan 1, 2025 – Dec 31, 2025Apr 1, 202620-F
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$103.2KJan 1, 2024 – Dec 31, 2024Apr 1, 202620-F
Net incomeNetIncomeLoss-$17.61MJan 1, 2025 – Dec 31, 2025Apr 1, 202620-F
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$15.66MJan 1, 2025 – Dec 31, 2025Apr 1, 202620-F
Total assetsAssets$78.26MDec 31, 2025Apr 1, 202620-F
Total liabilitiesLiabilities$26.36MDec 31, 2025Apr 1, 202620-F

New filings

Explore methodology ↗